UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000001260 |
|---|---|
| Receipt number | R000001534 |
| Scientific Title | A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil; OK-432 and Montanide; ISA-51 in patients with cancers expressing NY-ESO-1 antigen |
| Date of disclosure of the study information | 2008/07/24 |
| Last modified on | 2014/07/22 10:51:08 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2008/07/22 11:13:18 | ||
| 2 | Update | 2008/07/22 11:17:15 | UMIN ID1 UMIN ID2 |
|
| 3 | Update | 2008/07/24 14:58:03 | Condition Condition Classification by specialty |
|
| 4 | Update | 2008/07/24 14:59:15 | Date of disclosure of the study information |
|
| 5 | Update | 2010/08/23 13:15:47 | Recruitment status |
|
| 6 | Update | 2010/08/23 13:19:40 | Recruitment status |
|
| 7 | Update | 2010/08/23 13:22:02 | Last follow-up date Date of closure to data entry |
|
| 8 | Update | 2010/08/23 13:28:07 | Institutions |
|
| 9 | Update | 2010/08/23 13:28:38 | Recruitment status |
|
| 10 | Update | 2011/01/24 12:20:38 | Recruitment status |
|
| 11 | Update | 2011/07/22 09:07:03 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 12 | Update | 2012/01/24 08:36:56 | URL releasing protocol Publication of results URL related to results and publications Results Results |
|
| 13 | Update | 2013/01/22 09:05:56 | Last follow-up date Date of closure to data entry |
|
| 14 | Update | 2014/01/22 09:22:25 | Email |
|
| 15 | Update | 2014/07/22 10:51:08 | Recruitment status Date trial data considered complete Date analysis concluded Publication of results |
